EMG Biofeedback Training for Multiple Sclerosis
(MSBAL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help people with multiple sclerosis (MS) improve their balance. It compares novel EMG biofeedback training, which uses sensors to guide movements, with traditional balance exercises. The researchers aim to determine if this new method provides better, longer-lasting balance improvements. Individuals with MS who can walk and experience balance difficulties might be suitable for this trial. As an unphased trial, it offers participants the chance to contribute to innovative research that could lead to new balance improvement methods for MS.
Will I have to stop taking my current medications?
You won't have to stop taking your current medications, but you must agree not to change the dosage or start new medications during the study.
What prior data suggests that this EMG Biofeedback training method is safe for individuals with multiple sclerosis?
Research has shown that EMG Biofeedback Training, which uses sensors to provide feedback during exercise, has been tested for safety in previous studies. This training is generally well-tolerated, with few reports of side effects. The sensors are non-invasive and adhere to the skin like a band-aid.
Due to the lack of detailed side effect data from past studies, this trial is labeled as "Not Applicable" for study phase. This often indicates an early research study or involves a device or technique already considered safe, suggesting no known serious safety concerns. Participants often find this feedback training engaging and easy to follow.
The Traditional Balance Exercise Training, used for comparison, involves exercises commonly recommended by physiotherapists. These exercises are widely used and have a strong safety record, with most people handling them without issues.
In summary, both training methods in this trial appear safe based on past studies and their nature.12345Why are researchers excited about this trial?
Researchers are excited about the Integrated Dual-task EMG Biofeedback Training for multiple sclerosis because it offers a novel way to enhance motor and cognitive functions simultaneously. Unlike traditional physiotherapy, which often focuses on separate physical exercises, this approach integrates biofeedback with a video game, Tetris, to challenge both the mind and body. By linking specific muscle movements to game commands and shuffling these commands each session, it encourages patients to adapt and think critically, potentially improving both muscle coordination and cognitive flexibility. This dual-task method could provide a more engaging and holistic rehabilitation experience for those with multiple sclerosis.
What evidence suggests that this EMG Biofeedback Training is effective for improving balance in individuals with multiple sclerosis?
Research has shown that dual-task EMG Biofeedback training, which participants in this trial may receive, can help people with multiple sclerosis improve their balance. This training combines muscle feedback with mental tasks, and previous studies have demonstrated that it enhances walking ability and speed. Early findings suggest that adding mental tasks can improve motor skills by simultaneously challenging both the brain and body. This method uses sensors to provide real-time feedback, helping users adjust their movements for better balance. While traditional balance exercises, part of another treatment arm in this trial, work well, EMG Biofeedback training might offer extra benefits by involving both the mind and body.12346
Are You a Good Fit for This Trial?
This trial is for individuals with Multiple Sclerosis who are looking to improve their balance. Participants will be involved in a 6-week training program, with follow-up after three months. The study aims to include people at different levels of disability but has not specified any exclusion criteria.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either EMG Biofeedback training or traditional balance exercise training for 6 weeks, with three 30-minute sessions per week
Follow-up
Participants are monitored for balance and related outcomes 3 months after the end of training
What Are the Treatments Tested in This Trial?
Interventions
- Integrated Dual-task EMG Biofeedback Training
Integrated Dual-task EMG Biofeedback Training is already approved in Canada for the following indications:
- Improvement of balance in individuals with multiple sclerosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor
Multiple Sclerosis Society of Canada
Collaborator